ArticleBMC infectious diseases2025
Prevalence, trends, and correlates of HIV, syphilis, and HCV infections among male attendees at STD clinics in Southwest China: a 13-year cross-sectional study (2010-2022).
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Syndemic geographic patterns of integrated diseases during the Libyan armed conflict; a new aspect for public health care intervention?Frontiers in epidemiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
backgroundSexually transmitted infections (STIs) impose a substantial health burden and pose a significant threat to human health. However, data regarding long-term epidemiology patterns of STIs among high-risk groups are scarce. This study aimed to evaluate the prevalence, trends, and correlates of HIV, syphilis, and HCV among male attendees at sexually transmitted disease (STD) clinics in Southwest China.
methodsSerial cross-sectional surveys were performed annually among male STD clinic attendees in Southwest China from 2010 to 2022. Blood specimens were collected to test HIV, syphilis, and HCV infections. Mann-Kendall trend test was used to assess the trends of HIV, syphilis, and HCV prevalence. Rare even logistic regression model (relogit) was used to identify correlates of HIV, syphilis, and HCV infections.
resultsThis study included a total of 23,964 male attendees at STD clinics. The prevalence of HIV, syphilis, and HCV among participants was 0.98%, 2.16%, and 0.61%, respectively. While the prevalence of syphilis and HCV decreased from 3.64% to 1.81% in 2010 to 1.05% and 0.38% in 2022, the HIV prevalence did not show a downward trend. Relogit analysis revealed that participants with a history of STD had significantly increased risks of HIV (aOR = 1.90, 95%CI: 1.14-3.15) and HCV (aOR = 4.91, 95%CI: 3.22-7.49) infections. Participants who had ever engaged in homosexual behavior had significantly increased risks of HIV (aOR = 14.66, 95%CI: 5.49-39.14) and syphilis (aOR = 3.95, 95%CI:1.41-13.71) infections. Age also played a role, with those aged 50 years and above having a higher likelihood of HIV infection (aOR = 2.55, 95%CI: 1.91-3.39), while those under 50 years were more likely to be infected with HCV (aOR = 1.94, 95%CI: 1.19-3.16). Moreover, individuals of Han ethnicity were more likely to be infected with syphilis (aOR = 2.12, 95%CI: 1.75-2.57) and HCV (aOR = 1.65, 95%CI: 1.16-2.33). Being married or cohabiting increased the likelihood of syphilis infection (aOR = 1.40, 95%CI: 1.09-1.80), and a history of intravenous drug use (IDU) significantly increased the risk of HCV infection (aOR = 10.97, 95%CI: 5.21-23.12).
conclusionsThis study found a low prevalence of HIV, syphilis, and HCV among male attendees at STD clinics. Despite the declining prevalence of syphilis and HCV, HIV prevalence did not show a downward trend. This underscores the crucial need for continued and targeted prevention efforts, especially promoting STIs testing for men who have sex with men (MSM) and individuals with a history of intravenous drug use (IDU).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.